News & Opinion
Top 10 Innovations
Cell & Molecular Biology
Disease & Medicine
Ecology & Environment
Genetics & Genomics
Pharma & Biotech
Image of the Day
Week in Review: August 29–September 2
Jef Akst | Sep 2, 2016
Roger Tsien dies; the CRISPR patent dispute you’ve never heard of; immunotherapy for Alzheimer’s; Tasmanian devils developing resistance to transmissible cancer
Do Patents Promote or Stall Innovation?
Catherine Offord | May 31, 2016
A petition recently filed with the Supreme Court triggers renewed debate about the role of patents in the diagnostics sector.
“Heroes of CRISPR” Disputed
Tracy Vence | Jan 19, 2016
Critics have harsh words for the Broad Institute’s Eric Lander and
over a recent perspective piece describing the history of CRISPR.
Opinion: Translation Nation
Kathleen Marsman and Lisa McKerracher | Nov 18, 2015
What’s in store for commercialization grants at the Canadian Institutes of Health Research?
Picks: January 29, 2014
Tracy Vence | Jan 29, 2015
Celebrating lab techs; Myriad settles suits; publish in top-tier journals or perish
Keeping Up with IP
Kate Yandell | Aug 31, 2014
It’s never too early to start thinking about intellectual property rights—even for biologists doing basic research.
Yet Another Lawsuit over Genetic Tests
Tracy Vence | Jun 17, 2014
Myriad Genetics, the company originally behind tests for the cancer-associated BRCA mutations, is suing another competitor for patent infringement.
Week in Review: August 19–23
Tracy Vence | Aug 23, 2013
The importance of smORFs; America Invents Act and innovation in biotech; birds adjust their behavior to avoid cars; in defense of fundamental science
Opinion: AIA Does Not Discriminate
G. Nagesh Rao | Aug 21, 2013
The America Invents Act (AIA) was a step in the right direction for US competitiveness and open innovation.
Medicines for the World
Suerie Moon and Ellen â??t Hoen, Suerie Moon and Ellen â??t Hoen | Sep 30, 2012
A global R&D treaty could boost innovation and improve the health of the world’s poor—and rich.